AIG-Onco1

N/A

Report date: 2024/02/22 10:20:38

NME

Base Information

Drug NameAIG-Onco1

Drug Alias NameAIG-Onco1

ClassificationOther

Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors

TargetsGTPase KRas

Therapy Area/IndicationsPancreatic NeoplasmsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAIGEN Sciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A